🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.400
-0.160 (-10.26%)
At close: Nov 19, 2026, 4:00 PM EST
1.427
+0.027 (1.93%)
After-hours: Nov 19, 2026, 7:30 PM EST

Acrivon Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
47.5441.539.8236.0229.5299.6
Short-Term Investments
30.2277.08139.6691.4498.23-
Cash & Short-Term Investments
77.75118.58179.48127.46127.7599.6
Cash Growth
-39.85%-33.93%40.81%-0.23%28.26%6192.04%
Prepaid Expenses
1.331.862.152.234.340.81
Total Current Assets
79.08120.45181.63129.69132.1100.41
Property, Plant & Equipment
5.537.428.037.916.865.79
Long-Term Investments
--5.09-41.88-
Long-Term Deferred Charges
-0.5----
Other Long-Term Assets
1.141.361.850.670.390.39
Total Assets
85.75129.72196.59138.27181.23106.59

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.622.280.765.050.90.96
Accrued Expenses
12.5512.0715.47.384.141.22
Current Portion of Leases
1.111.171.060.880.730.66
Current Unearned Revenue
----0.070.07
Other Current Liabilities
-0.14--0.67-
Total Current Liabilities
14.2815.6617.2113.36.522.91
Long-Term Leases
0.691.542.593.774.244.96
Total Liabilities
14.9717.219.817.0710.757.88

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.040.030.030.020.020
Additional Paid-In Capital
400.54387.26373.28237.68226.581.05
Retained Earnings
-329.78-274.88-196.98-116.42-56.03-24.87
Comprehensive Income & Other
-0.030.110.45-0.08-0.1-
Total Common Equity
70.77112.52176.79121.2170.48-23.81
Shareholders' Equity
70.77112.52176.79121.2170.4898.71
Total Liabilities & Equity
85.75129.72196.59138.27181.23106.59

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1.82.713.654.644.965.63
Net Cash (Debt)
75.95115.87175.84122.81122.7993.98
Net Cash Growth
-39.85%-34.10%43.17%0.02%30.66%6062.30%
Net Cash Per Share
1.873.015.205.5629.7953.90
Filing Date Shares Outstanding
42.9138.7431.3522.6421.921.77
Total Common Shares Outstanding
42.9131.6531.2322.5221.921.77
Working Capital
64.8104.78164.42116.39125.5897.49
Book Value Per Share
1.653.565.665.387.78-13.45
Tangible Book Value
70.77112.52176.79121.2170.48-23.81
Tangible Book Value Per Share
1.653.565.665.387.78-13.45
Machinery
-7.296.383.132.510.35
Construction In Progress
-0.920.061.31--
SEC Filings: 10-K · 10-Q